Search Results
Results found for "cryo-EM"
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
. 👉 If your roadmap is full of scientific deliverables but empty of decision triggers, you’re burning
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
target to avoid adverse effects Why GPCR Imaging Tools Matter More Than Ever This tool could not have emerged
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Emerging direction: Genetics + receptor-distribution mapping. Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Emerging direction: Treatment sequencing + guided de-escalation. Emerging direction: Peptide–drug conjugates for precision targeting.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Kenakin emphasizes, “Schild plots don’t just confirm competition—they expose when competition is an illusion
- How GPCR Spatial Signaling Sparked a Scientific Journey
The Accidental Beginning Michelle hadn’t mapped out a scientific empire. She emphasizes leadership not as titles but as creating spaces where science thrives . For innovators and biotech strategists, stories like Michelle’s reveal how scientific leadership emerges
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
From these efforts emerged the concept of privileged structures : chemical backbones that show repeat And occasionally, new chemistry emerges from an unexpected source: Side effects.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
To tackle these, the lab employs molecular docking, molecular dynamics simulations, and ligand-based
- From Failed Experiments to Predictive GPCR Models
Embracing Complexity and Failure Carlsson’s approach to modeling is rooted in scientific humility. He emphasizes that not every question can be answered computationally—and that saying “we don’t know” Still, he emphasizes that data limitations remain a major challenge, especially when it comes to small Until better datasets emerge, predictive modeling will continue to rely on creative integration of computational
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Breakthroughs this week: nanomedicines targeting PAR2 for sustained analgesia; Emerging Voices in GPCR
- Innovative Data-Driven Solutions: The pHSense Revolution
This innovation emerged from years of foundational work in photophysics and GPCR pharmacology.
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Embark on this week’s thrilling updates in GPCR research, learning opportunities, and industry developments If you want to enhance your brand, email Hello@DrGPCR.com for sponsorship opportunities. Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and
- Dr. GPCR Updates
These methods will provide scientists with direct access to emerging tools and insights. Tom Sakmar, Emily Lorenzen, and Ilana Kotliar about creating a multiplex system with DUET-tagged constructs GPR45 steps up: A previously orphan receptor emerges as a powerful target for appetite and obesity control
- New Tools, Smart Signals, and The Kenakin Brief
It emphasizes scaffold selection, linker optimization, and assay compatibility to enhance target binding
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
But those failures are where new paths emerge, often leading to transformative tools like the IP1 assay Instead of chasing linear progress, Eric encourages young scientists to stay playful longer—embracing Eric Trinquet Built to Fail, Built to Win: Inside the IP1 Assay Origin Story The IP-One assay didn’t emerge
- Understanding Enzyme Inhibition In GPCR Discovery Programs
From failing fast to embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
This lecture challenges scientists to move beyond binary inhibition data and embrace a systems-level
- The Truth About GPCR Product Launches: Years in the Making
But a pattern emerged: some scaffolds showed dual responsiveness to pH through lifetime and brightness
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
With extreme overexpression, constitutive activity emerges, exposing inverse agonism. Emerging drug hunters cannot afford to test compounds in default conditions alone. What emerges is not just more data—it’s the right data, positioned to inform strategic decision-making
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
a delay is introduced between the time of excitation of the donor and the readout of the acceptor’s emission distance between donor and acceptor is close enough, energy is transferred, and a second, short-lived emission Measuring emission at both donor (usually 620nm) and acceptor (typically 665nm) wavelengths allows for The delay introduced in HTRF between excitation and emission detection lets the background signals dissipate By using donor-acceptor pairs with different emission spectra that don’t overlap, researchers can design
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Emerging GPCR Therapeutic Targets in CNS Drug Discovery GPCRs have been studied for decades, but there As mentioned in previous posts, CELT-335, one of our fluorescent compounds, was successfully employed
- The Five Traps of Ignoring Kinetics
Once you do, the irregular potency vanishes, and the true profile emerges.
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
By measuring the way these cells scatter light and emit fluorescence, they can be identified, quantified Emission spectra and overlap : cell autofluorescence is usually found in the green region of the emission
- From Snapshots to Predictions: Why Mechanism of Action Matters
But if you deconvolute into affinity and efficacy, a rich SAR emerges.
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
He emphasizes that building a startup is not simply a continuation of research — it requires a mindset By staying grounded in scientific rigor while embracing the tools of business and technology, he’s built
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
Her choice to stay in academia isn’t about rejecting industry—it’s about embracing the freedom to chase Her story is a reminder that clarity often emerges through action, not planning.
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Competitive Edge: Stay informed on emerging public health threats and the scientific research aimed
- Fluorescence Polarization in GPCR Research
When polarized light hits a free fluorescent ligand, its rotation speed is so fast that the emission the polarized light hits the bound fluorescent ligand, the slower rotation speed means a polarized emission
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
For emergency responders, this insight is critical: oxygen saturation alone is not always a reliable
- Advantages of Fluorescent Probes in GPCR Assays
This happens when prolonged exposure to light in the excitation range causes the emission signal to decrease This can be fixed by using fluorescent dyes that emit at longer wavelengths, where fluorescence from using Fluorescent Probes The preparation of the cellular system is the most common starting point for employing Fluorescent ligands: Bringing light to emerging GPCR paradigms.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
Figure 1.Combinational optical spectra of terbium (Tb) and CELT-335: The terbium (donor) emission spectrum acceptor is sufficient for a transmission of energy to occur between the Tb and fluorophore, which will emit






























